Human immunodeficiency virus type 1 fitness is a determining factor in viral rebound and set point in chronic infection

被引:40
作者
Trkola, A
Kuster, H
Leemann, C
Ruprecht, C
Joos, B
Telenti, A
Hirschel, B
Weber, R
Bonhoeffer, S
Günthard, HF
机构
[1] Univ Zurich Hosp, Div Infect Dis & Hosp Epidemiol, CH-8091 Zurich, Switzerland
[2] ETH Zentrum, Inst Ecol, CH-8092 Zurich, Switzerland
[3] Univ Hosp Geneva, Div Infect Dis, CH-1211 Geneva, Switzerland
[4] Univ Lausanne Hosp, Div Infect Dis, CH-1011 Lausanne, Switzerland
关键词
D O I
10.1128/JVI.77.24.13146-13155.2003
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Human immunodeficiency virus type 1 (HIV-1) isolates from 20 chronically infected patients who participated in a structured treatment interruption (STI) trial were studied to determine whether viral fitness influences reestablishment of viremia. Viruses derived from individuals who spontaneously controlled viremia had significantly lower in vitro replication capacities than viruses derived from individuals that did not control viremia after interruption of antiretroviral therapy (ART), and replication capacities correlated with pre-ART and post-STI viral set points. Of note, no clinically relevant improvement of viral loads upon STI occurred. Virus isolates from controlling and noncontrolling patients were indistinguishable in terms of coreceptor usage, genetic subtype, and sensitivity to neutralizing antibodies. In contrast, viruses from controlling patients exhibited increased sensitivity to inhibition by chemokines. Sensitivity to inhibition by RANTES correlated strongly with slower replication kinetics of the virus isolates, suggesting a marked dependency of these virus isolates on high coreceptor densities on the target cells. In summary, our data indicate that viral fitness is a driving factor in determining the magnitude of viral rebound and viral set point in chronic HIV-1 infection, and thus fitness should be considered as a parameter influencing the outcome of therapeutic intervention in chronic infection.
引用
收藏
页码:13146 / 13155
页数:10
相关论文
共 50 条
[1]   EXPRESSION AND CHARACTERIZATION OF CD4-IGG(2), A NOVEL HETEROTETRAMER THAT NEUTRALIZES PRIMARY HIV TYPE-1 ISOLATES [J].
ALLAWAY, GP ;
DAVISBRUNO, KL ;
BEAUDRY, GA ;
GARCIA, EB ;
WONG, EL ;
RYDER, AM ;
HASEL, KW ;
GAUDUIN, MC ;
KOUP, RA ;
MCDOUGAL, JS ;
MADDON, PJ .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1995, 11 (05) :533-539
[2]   New insights into evaluating effective T-cell responses to HIV [J].
Allen, TM ;
Watkins, DI .
AIDS, 2001, 15 :S117-S126
[3]   IN-VITRO EVOLUTION OF A NEUTRALIZING HUMAN-ANTIBODY TO HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 TO ENHANCE AFFINITY AND BROADEN STRAIN CROSS-REACTIVITY [J].
BARBAS, CF ;
HU, D ;
DUNLOP, N ;
SAWYER, L ;
CABABA, D ;
HENDRY, RM ;
NARA, PL ;
BURTON, DR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (09) :3809-3813
[4]   The effect of highly active antiretroviral therapy on binding and neutralizing antibody responses to human immunodeficiency virus type 1 infection [J].
Binley, JM ;
Trkola, A ;
Ketas, T ;
Schiller, D ;
Clas, B ;
Little, S ;
Richman, D ;
Hurley, A ;
Markowitz, M ;
Moore, JP .
JOURNAL OF INFECTIOUS DISEASES, 2000, 182 (03) :945-949
[5]   In vitro replication kinetics of human immunodeficiency virus type 1 (HIV-1) variants in relation to virus load in long-term survivors of HIV-1 infection [J].
Blaak, H ;
Brouwer, M ;
Ran, LJ ;
de Wolf, F ;
Schuitemaker, H .
JOURNAL OF INFECTIOUS DISEASES, 1998, 177 (03) :600-610
[6]   In vivo HIV-1 infection of CD45RA+CD4+ T cells is established primarily by syncytium-inducing variants and correlates with the rate of CD4+ T cell decline [J].
Blaak, H ;
van't Wout, AB ;
Brouwer, M ;
Hooibrink, B ;
Hovenkamp, E ;
Schuitemaker, H .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (03) :1269-1274
[7]   Individual contributions of mutant protease and reverse transcriptase to viral infectivity, replication, and protein maturation of antiretroviral drug-resistant human immunodeficiency virus type 1 [J].
Bleiber, G ;
Munoz, M ;
Ciuffi, A ;
Meylan, P ;
Telenti, A .
JOURNAL OF VIROLOGY, 2001, 75 (07) :3291-3300
[8]   Procedures for reliable estimation of viral fitness from time-series data [J].
Bonhoeffer, S ;
Barbour, AD ;
De Boer, RJ .
PROCEEDINGS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES, 2002, 269 (1503) :1887-1893
[9]   Phototyping: Comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP) [J].
Bunce, M ;
ONeill, CM ;
Barnardo, MCNM ;
Krausa, P ;
Browning, MJ ;
Morris, PJ ;
Welsh, KI .
TISSUE ANTIGENS, 1995, 46 (05) :355-367
[10]   The influence of HLA genotype on AIDS [J].
Carrington, M ;
O'Brien, SJ .
ANNUAL REVIEW OF MEDICINE, 2003, 54 :535-551